Issue 19

Kimi K3 ships open weights as a shadow token-reseller market comes into view

Kimi K3's open weights landed as promised, while an underground token-reseller market exposed how LLM API economics create fraud incentives. In pharma, argenx paid $2.2B for a phase 2 vitiligo drug and Merck staged voluntary licensing for a monthly HIV PrEP pill ahead of approval. The economy section covers the declining cross-field transmission of scientific ideas and a counterintuitive finding on the real cost of raising children.

7 min read process

ai Kimi K3 ships open weights; a shadow market exploits LLM pricing gaps

Kimi-K3 Releases on HuggingFace 7/27

Moonshot AI's Kimi K3 landed on Hugging Face on July 27, delivering on the open-weights release that was promised a week earlier. The 2.8 trillion parameter mixture-of-experts model reached 567 points and 256 comments on Hacker News within hours of posting, consistent with broad practitioner interest. Kimi K3 had previously been reported as the first open-weights model to reach frontier-level coding performance at that scale, at roughly 4.6 times lower cost per token than comparable closed models.

Hacker News (front page)
Claude Sonnet 4.6

An Inside Look at the Relay Market Powering Token Resellers and Fraud

Matt Lenhard, writing via Simon Willison, investigated a market of LLM token resellers operating primarily in China. Resellers pool API keys and sell discounted access through proxy services, funding the discounts by abusing free trials, routing requests through unprotected vendor support bots, or using stolen credit cards. The market creates a fraud layer between model providers and end users that standard billing and rate-limiting controls do not fully address.

Simon Willison
Claude Sonnet 4.6

software TypeScript compiled to native; PostgreSQL internals illustrated

Scriptc by Vercel: TypeScript-to-Native compiler, no JavaScript engine in binary

Vercel Labs released Scriptc, a TypeScript-to-native compiler that produces binaries containing no JavaScript engine. The project removes the V8 or Bun runtime from the output artifact entirely, a departure from the standard TypeScript deployment model. Early Hacker News discussion focused on binary size, startup latency, and compatibility with TypeScript features that depend on runtime reflection.

Hacker News (front page)
Claude Sonnet 4.6

PGSimCity - How PostgreSQL Works

Nikolay Samokhvalov published PGSimCity, a visual simulation of how PostgreSQL processes queries internally. The project uses a city metaphor to illustrate execution stages including planning, buffer management, and lock handling. It drew 730 Hacker News points, suggesting the explainer fills a genuine gap for developers who use Postgres without a detailed mental model of its internals.

Hacker News (front page)
Claude Sonnet 4.6

pharma Autoimmune M&A and a monthly HIV pill staged for global access

STAT+: Argenx to buy Forte Biosciences for $2.2B

Argenx agreed to acquire Forte Biosciences for $2.2 billion, adding a phase 2 drug candidate being studied in vitiligo and celiac disease to its autoimmune pipeline. Forte's asset is still in mid-stage development, making the price a significant bet on a program that has not yet demonstrated phase 3 efficacy. The deal extends argenx's strategy of building a multi-indication autoimmune franchise around its FcRn inhibitor platform.

STAT News
Claude Sonnet 4.6

Merck stages expanded access to monthly HIV PrEP pill ahead of approval

Merck signed voluntary licensing agreements allowing generic manufacturers to produce alimatravir, its investigational once-monthly HIV PrEP pill, in lower-income countries before any regulatory submission. Gilead had taken a similar step with lenacapavir earlier this year. The move follows pressure on HIV prevention developers to prevent a repeat of the access gap that slowed rollout of earlier antiretroviral drugs in low-income settings.

Fierce Pharma
Claude Sonnet 4.6

Labcorp launches DTC 'Genetic Health Panel' to seek out multiple diseases

Labcorp launched Marker, a direct-to-consumer genetic testing panel that analyzes 163 genes and screens for risk across more than 100 hereditary health conditions. The product enters a market that includes 23andMe's health panels and several clinical-grade competitors. DTC genetic testing has faced ongoing regulatory scrutiny over how results are communicated and how variants of uncertain significance are disclosed to consumers without clinical context.

Fierce Biotech
Claude Sonnet 4.6

STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease

Oak Hill Bio, a new company backed by RA Capital, is developing an Angelman syndrome treatment that will compete directly with programs at Ultragenyx and Ionis. Angelman syndrome is a rare neurogenetic disorder with no approved treatments; both incumbent programs are in clinical development. RA Capital's backing signals continued institutional appetite for rare neurological disease despite a competitive field.

STAT News
Claude Sonnet 4.6

healthtech Medical schools and mental health: two cautious institutional responses

STAT+: As some medical schools embrace RFK Jr.'s nutrition push, they deftly sidestep MAHA priorities

Several US medical schools told STAT they are adding nutrition content to their curricula in response to HHS Secretary Robert F. Kennedy Jr.'s push, while carefully avoiding topics associated with his broader MAHA agenda, including vaccine skepticism and opposition to certain approved medications. The selective adoption reflects institutions trying to respond to a federal health official without endorsing positions that contradict established clinical evidence.

STAT News
Claude Sonnet 4.6

economy Scientific knowledge silos, child cost data, and South American food security

The Decline in the Transmission of Scientific Ideas

A study cited by Tyler Cowen found that cross-field diffusion of scientific ideas has fallen substantially over the past four decades. The decline tracks closely with increasing specialization in scientific language; papers using more technical terminology are adopted less broadly outside their home field. The researchers developed a theory predicting that specialization compounds over time, widening the gap between fields that might otherwise inform each other.

Marginal Revolution (Tyler Cowen)
Claude Sonnet 4.6

In relative terms, maybe children do not cost more than before?

A new child cost index cited by Marginal Revolution found that despite rapid inflation in childcare and tuition, the overall cost of raising children has not risen much relative to adult spending. Children face lower exposure to shelter costs, and price growth in other parts of the child consumption basket has been slower. Households are devoting more real resources to children than in 1990, but the increase parallels overall income growth rather than outpacing it.

Marginal Revolution (Tyler Cowen)
Claude Sonnet 4.6

Further progress in South America

A UN Food and Agriculture Organisation report published July 21 found that hunger in South America has fallen by one-third since 2020. Just 3.5% of the region's population now consumes insufficient calories, the lowest share in the world. The FAO report found the pace of decline in South America has been faster than in any other region over the same period.

Marginal Revolution (Tyler Cowen)
Claude Sonnet 4.6
Everything else this period 164

Items that came through the feeds this period but didn't graduate to a full write-up.

ai 79

3Blue1Brown

a16z (YouTube)

AI Explained

Alpha Signal

Astral Codex Ten (Scott Alexander)

Cloudflare Blog

CodeEmporium

Dwarkesh Patel (YouTube)

Fireship

Hacker News (front page)

Hugging Face Blog

InfoQ

Interconnects (Nathan Lambert)

JetBrains AI Blog

Latent Space

OpenAI News

r/MachineLearning

Simon Willison

software 8

pharma 36

BioPharma Dive

Fierce Biotech

Fierce Pharma

Healthcare Dive

STAT News

Works in Progress

healthtech 1

Health Tech Nerds

economy 25

culture 7

startups 6

vc 2